| 21. - 23.03. 2012 |
CPhI Japan, Tokyo Big Sight 2012
|
| 26. - 28.06. 2012 |
CPhI China, Shanghai 2012
|
| 21. - 23.08. 2012 |
CPhI South America, Sao Paulo 2012
|
| 09. - 11.10. 2012 |
CPhI WORLDWIDE Feria der Madrid, Spain 2012
Join us in Madrid for CPhI Worldwide 2012, the world’s leading pharmaceutical networking event Visit us in Hall No. 3 Stand 3A01 Pharma Action your number one for Heparin made in Germany! |
| 21. - 23.11. 2012 |
CPhI India, Bombay Exhibtion Center, Mumbai 2012
|
| 21.12.2011 |
New Heparin qualities under R&D
check out our latest developments...
|
| 02.02.2012 |
BREAKING NEWS: PHARMA ACTION's NEW HEPARIN PRODUCTION UNIT APPROVED
PHARMA ACTION proudly announces, that the brand new Heparin production unit in Berlin has succesful passed the official MoH audit
|
| 14.02.2011 |
EDQM excludes biological active substance from CEP procedure
EDQM does not accept new CEP applications for biological active substance.
Further information (opens in new browser-window): Position paper Concerned substances |
PHARMA ACTION GmbH | Kurfuerstendamm 133 | 10711 Berlin/Germany |
email to office@pharma-action.com
or call 0049 30 - 890 44 99 - 0
» IMPRINT
» STC